01 100ASTRAZENECA AB
02 334BOEHRINGER INGELHEIM
03 124JANSSEN PHARMS
04 26MSD SUB MERCK
05 1SANTARUS INC
06 1SUN PHARM
07 16TAKEDA PHARMS USA
01 510022379*PED
02 1210258637*PED
03 410596120*PED
04 96515117
05 57326708
06 97407955
07 127579449
08 127713938
09 17780987
10 27785627
11 27807689
12 97919598
13 247943582
14 87943788
15 27959946
16 48080580
17 28173663
18 248222219
19 28288539
20 28414921
21 98501698
22 248513202
23 48551957
24 78628799
25 58673927
26 58685934
27 48716251
28 88785403
29 38846695
30 98883805
31 28900638
32 29101660
33 99155705
34 29173859
35 49308204
36 29320714
37 39339472
38 99415016
39 49439902
40 49555001
41 99616028
42 169949997
43 89949998
44 19962336
45 910022379
46 1210258637
47 410406172
48 1610596120
49 410610489
50 410610489*PED
51 310973827
52 310973827*PED
53 1211090323
54 1211090323*PED
55 311564886
56 411576894
57 411813275
58 2411833166
59 511911388
60 1212115179
61 96515117*PED
62 57326708*PED
63 97407955*PED
64 127579449*PED
65 127713938*PED
66 97919598*PED
67 87943582*PED
68 87943788*PED
69 88222219*PED
70 28414921*PED
71 98501698*PED
72 88513202*PED
73 48551957*PED
74 58673927*PED
75 58685934*PED
76 48716251*PED
77 38846695*PED
78 98883805*PED
79 59155705*PED
80 29173859*PED
81 59415016*PED
82 29555001*PED
83 99616028*PED
84 89949997*PED
85 89949998*PED
01 121Y
02 481Blank
01 230Y
02 372Blank
01 82024-07-30
02 22025-03-15
03 12025-03-23
04 242025-04-11
05 92025-05-02
06 22025-06-24
07 102025-07-13
08 92025-10-04
09 82025-10-11
10 92025-11-02
11 92025-11-26
12 92026-04-04
13 92026-05-26
14 42026-07-31
15 52026-11-24
16 22027-01-22
17 122027-04-15
18 72027-05-04
19 52027-05-24
20 92027-06-20
21 82027-07-14
22 122027-10-15
23 72027-11-04
24 242027-12-03
25 92027-12-20
26 82028-01-14
27 42028-03-21
28 82028-06-03
29 22028-06-27
30 22028-07-21
31 122028-08-01
32 42028-09-21
33 22029-01-21
34 122029-02-01
35 22029-02-03
36 242029-02-26
37 212029-04-02
38 22029-05-24
39 82029-08-26
40 132029-10-02
41 42029-10-14
42 92029-12-16
43 122030-02-11
44 52030-04-10
45 42030-04-14
46 92030-05-21
47 52030-05-26
48 32030-06-04
49 42030-06-15
50 92030-06-16
51 42030-07-06
52 42030-07-13
53 42030-09-30
54 82030-10-21
55 92030-11-12
56 52030-11-21
57 52030-11-26
58 32030-12-04
59 42031-03-30
60 92031-05-12
61 192032-03-07
62 42032-09-07
63 42033-03-06
64 22033-09-06
65 522034-04-03
66 162034-05-17
67 82034-06-11
68 242034-10-03
69 82034-11-17
70 82034-12-11
71 12035-05-01
Patent Expiration Date : 2025-10-04
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 6515117
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 205649
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2025-10-04
Patent Expiration Date : 2025-10-04
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 6515117
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 205649
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2025-10-04
Patent Expiration Date : 2027-06-20
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8501698
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205649
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2027-06-20
Patent Expiration Date : 2025-10-04
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 6515117
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 205649
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2025-10-04
Patent Expiration Date : 2027-06-20
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8501698
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205649
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2027-06-20
Patent Expiration Date : 2030-05-26
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8685934
Drug Substance Claim :
Drug Product Claim :
Application Number : 205649
Patent Use Code : U-1522
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2030-05-26
Patent Expiration Date : 2025-10-04
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE
US Patent Number : 6515117
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 210874
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2025-10-04
Patent Expiration Date : 2025-10-04
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE
US Patent Number : 6515117
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 210874
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2025-10-04
Patent Expiration Date : 2027-06-20
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE
US Patent Number : 8501698
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 210874
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2027-06-20
Patent Expiration Date : 2027-06-20
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE
US Patent Number : 8501698
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 210874
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2027-06-20
LOOKING FOR A SUPPLIER?
